David Scadden - Jun 1, 2021 Form 4 Insider Report for Magenta Therapeutics, Inc. (MGTA)

Role
Director
Signature
/s/ Cindy Driscoll, Attorney-in-Fact for David Scadden
Stock symbol
MGTA
Transactions as of
Jun 1, 2021
Transactions value $
$0
Form type
4
Date filed
6/3/2021, 06:30 PM
Previous filing
Jun 2, 2021
Next filing
Jun 7, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MGTA Stock Option (Right to Buy) Award $0 +18.2K $0.00 18.2K Jun 1, 2021 Common Stock 18.2K $12.91 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest and become exercisable in full upon the earlier to occur of (a) June 1, 2022 or (b) the next annual meeting of the Issuer's stockholders.